Literature DB >> 34412935

Functional Disabilities and Psychiatric Symptoms in Primary Progressive Aphasia.

Christopher B Morrow1, Jeannie-Marie Sheppard Leoutsakos2, Chiadi U Onyike3.   

Abstract

OBJECTIVE: The aims of this study are to describe the chronology of functional disabilities in primary progressive aphasia (PPA), and to examine associations between psychiatric comorbidities and functional disabilities.
METHODS: We conducted a retrospective data analysis using subjects enrolled at Alzheimer's Disease Research Centers between 2005 and 2019. Data were obtained from the National Alzheimer's Coordinating Center database. We included subjects whose primary diagnosis was PPA. Functional status was coded as a binary variable for the following functions: ambulation, transaction skills, verbal communication, meal preparation, and self-care. Behavioral data derived from the Neuropsychiatric Inventory Questionnaire. Descriptive statistics and cox proportional hazard analyses were used to characterize the emergence of disabilities and their association with psychiatric comorbidities.
RESULTS: Data included 91 subjects with a clinical dementia rating scale of zero at baseline. At the initial visit, no individuals had impairments in self-care, while 7% had impairments in transactions, 3% in ambulation, and 2% in meal preparation. Ninety-three percent had language impairments at the onset of the study, and all by visit 4. By visit 5, 41% of patients had impairments in ambulation and in self-care, 49% were impaired in meal preparation and 70% had impairment in transactions. The presence of anxiety, depression, sleep disturbance and psychosis were all significantly associated with an increased risk for multiple functional disabilities.
CONCLUSION: These findings provide clinicians with guidance for forecasting disabilities and targeting interventions in PPA.
Copyright © 2021 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Frontotemporal dementia; disability; neuropsychiatric symptoms; primary progressive aphasia

Mesh:

Year:  2021        PMID: 34412935      PMCID: PMC9103777          DOI: 10.1016/j.jagp.2021.07.013

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   7.996


  46 in total

1.  A case of primary progressive aphasia associated with depression.

Authors:  Nahla Mahgoub; Jimmy Avari
Journal:  Int J Geriatr Psychiatry       Date:  2012-04       Impact factor: 3.485

2.  Neuropsychiatric aspects of primary progressive aphasia.

Authors:  Yasaman Fatemi; Bradley F Boeve; Joseph Duffy; Ronald C Petersen; David S Knopman; Vladimir Cejka; Glenn E Smith; Yonas E Geda
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

3.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

4.  Neuropsychiatric symptoms in primary progressive aphasia and apraxia of speech.

Authors:  Tarun D Singh; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Jennifer L Whitwell; Keith A Josephs
Journal:  Dement Geriatr Cogn Disord       Date:  2015-01-21       Impact factor: 2.959

Review 5.  Primary progressive aphasia: clinicopathological correlations.

Authors:  Murray Grossman
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

Review 6.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 7.  Semantic dementia: a unique clinicopathological syndrome.

Authors:  John R Hodges; Karalyn Patterson
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

Review 8.  Frontotemporal dementia: latest evidence and clinical implications.

Authors:  Juan Joseph Young; Mallika Lavakumar; Deena Tampi; Silpa Balachandran; Rajesh R Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-10

Review 9.  Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review.

Authors:  Jonathan Blackman; Marta Swirski; James Clynes; Sam Harding; Yue Leng; Elizabeth Coulthard
Journal:  J Sleep Res       Date:  2020-12-02       Impact factor: 3.981

Review 10.  Pimavanserin: Potential Treatment For Dementia-Related Psychosis.

Authors:  J Cummings; C Ballard; P Tariot; R Owen; E Foff; J Youakim; J Norton; S Stankovic
Journal:  J Prev Alzheimers Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.